Preterm birth
Large reviews and trials show a reduction in preterm birth, especially when baseline omega-3 status is low.
html
EPA and DHA participate in hormonal, inflammatory and structural pathways that become important at different stages of a woman's life, with particularly strong evidence in pregnancy and fetal development.
Pregnancy has the strongest evidence base; PCOS and dysmenorrhoea add evidence in specific contexts.
Large reviews and trials show a reduction in preterm birth, especially when baseline omega-3 status is low.
DHA is structural material for the brain and retina during fetal development.
Maternal supplementation increases DHA in the mother, breast milk and the baby's membranes.
Reviews of RCTs found improvements in some metabolic and hormonal markers in women with polycystic ovary syndrome.
Randomised trials found reduced dysmenorrhoea intensity and less need for rescue ibuprofen.
In pregnancy, ORIP studies showed that baseline status helps identify who has the greatest room to benefit from higher doses.
In women's health, some topics extend into other areas of the site: DHA links pregnancy to brain and the retina, while inflammatory balance connects to the page on chronic low-grade inflammation.
The 2018 Cochrane review included 70 trials and nearly 20,000 women.
19.927 women included in the review.
Approximate reduction of 11% across the trials.
Approximate reduction of 42% for early preterm birth.
PMID 30480773 →Related scientific studyORIP and subsequent analyses showed that the benefit of higher doses was concentrated mainly in women with low baseline status.
Large-scale Australian trial of prenatal omega-3 supplementation.
PMID 31509674 →Related scientific studyThe exploratory analysis showed a marked reduction in birth before 34 weeks in the group with low baseline status.
PMID 32034969 →Related scientific studyLater work went further in identifying the women who may benefit from a higher dose.
PMID 37068907 →Related scientific studyMeta-analyses and RCTs show improvements in insulin-resistance markers and some hormonal indicators in women with PCOS.
PMID 39275277 →Related scientific studyIn a double-blind crossover study, omega-3 reduced pain intensity and the need for rescue ibuprofen.
PMID 22261128 →Related scientific studyA classic RCT also found improvement in dysmenorrhoea symptoms with omega-3 supplementation.
PMID 8623866 →Related scientific studyOpen the material page to view the visual version, related references and the reviewed PDF for reading or sharing.
Continue from the article to reviewed presentations and return to the topic pages whenever you want to examine the evidence in more depth.